Update in treatment of peptic ulcer disease.
D000328:Adult; D000368:Aged; D000428:Alcohol Drinking; D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects; D001729:Bismuth / Q000627:therapeutic use; D002927:Cimetidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009942:Organometallic Compounds; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D011899:Ranitidine / Q000627:therapeutic use; D012008:Recurrence; D012907:Smoking; D013392:Sucralfate; D014629:Vagotomy, Proximal Gastric
D000863:Antacids; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D013392:Sucralfate; D002927:Cimetidine; D011899:Ranitidine; D000535:Aluminum; C002791:bismuth tripotassium dicitrate; D001241:Aspirin; D001729:Bismuth